Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -851.925 | -158.347 | -146.897 | -79.818 | 10.842 |
| Return on Equity (%) | 108.183 | 29.791 | 80.71 | -209.434 | 12.731 |
| Return on Invested Capital (%) | 978.982 | -1076.996 | -177.29 | -94.574 | 9.282 |
| Operating Margin (%) | -872.37 | -872.37 | -30852.982 | -888.893 | 14.259 |
| Net Profit Margin (%) | -961.851 | -961.851 | -30852.982 | -892.375 | 12.939 |
| Book Value Per Share | -2.95 | 0.89 | 3.171 | 3.902 | 4.908 |
| Earnings Per Share | -2.288 | -2.288 | -3.162 | -2.272 | 0.558 |
| Cash Per Share | 0.511 | 2.148 | 1.805 | 0.716 | 1.927 |
| Working Capital Per Share | -0.221 | 1.053 | 3.149 | 3.843 | 4.333 |
| Operating Profit Per Share | 0.238 | 0.238 | 0.01 | 0.226 | 4.036 |
| EBIT Per Share | -2.288 | -2.288 | -3.162 | -2.263 | 0.615 |
| EBITDA Per Share | -2.288 | -2.288 | -3.162 | -2.263 | 0.615 |
| Free Cash Flow Per Share | -2.288 | -2.288 | -3.151 | -2.249 | 0.56 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 5.99M | 5.99M | 7.02M | 66.51M | N/A |
| Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Shares Outstanding | N/A | 66.51M | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | 1.964 | N/A | N/A | N/A | -133.74 | N/A |
| Net Profit Margin (%) | N/A | N/A | 2.202 | N/A | N/A | N/A | -134.013 | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 325.43M |
| Price to Earnings Ratio | 6.26 |
| Price to Sales Ratio | 0.81 |
| Price to Cash Ratio | 1.81 |
| Price to Book Ratio | 0.71 |
| Dividend Yield | - |
| Shares Outstanding | 68.08M |
| Average Volume (1 week) | 2.35M |
| Average Volume (1 Month) | 1.46M |
| 52 Week Change | -73.05% |
| 52 Week High | 19.9488 |
| 52 Week Low | 1.575 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
